Martin R, Voskuhl R, Flerlage M, McFarlin D E, McFarland H F
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
Ann Neurol. 1993 Oct;34(4):524-35. doi: 10.1002/ana.410340405.
Although multiple sclerosis (MS) is thought to be an autoimmune disease, the target antigen of the immune response is unknown. Both myelin basic protein (MBP) and proteolipid protein (PLP) have been considered candidate autoantigens. Because the immune response to either foreign or self antigens is influenced by the genetic background of the host, the importance of these candidate antigens has been difficult to establish in humans because of genetic diversity. To eliminate genetic differences in MS patients and healthy controls, we have studied the MBP-specific T-cell response in 6 sets of identical twins, 3 of which were concordant and 3 discordant for MS. A total of 638 short-term T-cell lines were established and characterized for MBP-specific proliferative and cytotoxic activity, fine specificity, and human leukocyte antigen (HLA) restriction. Similar frequencies of MBP-specific T cells were observed in affected and unaffected individuals. A slightly higher percentage of cytotoxic T-cell lines was found in affected individuals. For most of the cell lines, the restriction elements were the HLA class II antigens that have been reported previously to be associated with MS; no important differences with respect to HLA restriction were found between the patients and healthy individuals. The peptide epitopes of MBP that were recognized most frequently by the T-cell lines were those previously shown to be immunodominant. Differences in specificity were seen in some discordant twins indicating that, despite genetic identity, the MBP-specific T-cell repertoire may be shaped differently. These findings indicate that differences in frequency, peptide specificity, or HLA restriction are not sufficient to implicate MBP-specific T cells in the pathogenesis of MS. However, the T-cell response to MBP may still represent one necessary component with disease occurring when this response is combined with other host characteristics such as regulation of cytokine-, adhesion molecule-, or HLA-antigen expression in the nervous system or immunoregulatory mechanisms.
尽管多发性硬化症(MS)被认为是一种自身免疫性疾病,但其免疫反应的靶抗原尚不清楚。髓鞘碱性蛋白(MBP)和蛋白脂蛋白(PLP)都曾被视为候选自身抗原。由于对异物或自身抗原的免疫反应受宿主遗传背景的影响,鉴于遗传多样性,这些候选抗原在人类中的重要性难以确定。为消除MS患者与健康对照之间的遗传差异,我们研究了6对同卵双胞胎中针对MBP的T细胞反应,其中3对双胞胎两人都患MS,3对双胞胎中有一人患病。共建立了638个短期T细胞系,并对其针对MBP的增殖和细胞毒性活性、精细特异性以及人类白细胞抗原(HLA)限制性进行了表征。在患病个体和未患病个体中观察到针对MBP的T细胞频率相似。在患病个体中发现细胞毒性T细胞系的比例略高。对于大多数细胞系而言,限制性元件是先前报道与MS相关的HLA II类抗原;患者与健康个体在HLA限制性方面未发现重要差异。T细胞系最常识别的MBP肽表位是先前显示具有免疫显性的表位。在一些不一致的双胞胎中观察到特异性差异,这表明尽管基因相同,但针对MBP的T细胞库可能形成方式不同。这些发现表明,频率、肽特异性或HLA限制性方面的差异不足以表明针对MBP的T细胞参与MS的发病机制。然而,对MBP的T细胞反应可能仍然是一个必要组成部分,当这种反应与其他宿主特征(如神经系统中细胞因子、黏附分子或HLA抗原表达的调节或免疫调节机制)结合时会引发疾病。